journal article·2023-11-29Open access

High-Fidelity Extrusion Bioprinting of Low-Printability Polymers Using Carbopol as a Rheology Modifier

Mabel Barreiro Carpio, Eduardo Gonzalez Martinez, Mohammadhossein Dabaghi, Julia Ungureanu, Aidee Veronica Arizpe Tafoya, David A. Gonzalez Martinez, Jeremy Alexander Hirota, Jose Manuel Moran-Mirabal

ACS Applied Materials & Interfaces· Volume 15· Issue 47

Abstract

Extrusion three-dimensional (3D) bioprinting is a promising technology with many applications in the biomedical and tissue engineering fields. One of the key limitations for the widespread use of this technology is the narrow window of printability that results from the need to have bioinks with rheological properties that allow the extrusion of continuous filaments while maintaining high cell viability within the materials during and after printing. In this work, we use Carbopol (CBP) as rheology modifier for extrusion printing of biomaterials that are typically nonextrudable or present low printability. We show that low concentrations of CBP can introduce the desired rheological properties for a wide range of formulations, allowing the use of polymers with different cross-linking mechanisms and the introduction of additives and cells. To explore the opportunities and limitations of CBP as a rheology modifier, we used ink formulations based on poly(ethylene glycol)diacrylate with extrusion 3D printing to produce soft, yet stable, hydrogels with tunable mechanical properties. Cell-laden constructs made with such inks presented high viability for cells seeded on top of cross-linked materials and cells incorporated within the bioink during printing, showing that the materials are noncytotoxic and the printed structures do not degrade for up to 14 days. To our knowledge, this is the first report of the use of CBP-containing bioinks to 3D-print complex cell-laden structures that are stable for days and present high cell viability. The use of CBP to obtain highly printable inks can accelerate the evolution of extrusion 3D bioprinting by guaranteeing the required rheological properties and expanding the number of materials that can be successfully printed. This will allow researchers to develop and optimize new bioinks focusing on the biochemical, cellular, and mechanical requirements of the targeted applications rather than the rheology needed to achieve good printability.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Additive Manufacturing and 3D Printing Technologies · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario L8S 4M1, Canada

Firestone Institute for Respiratory Health, Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario L8S 4M1, Canada

School of Biomedical Engineering, McMaster University, Hamilton, Ontario L8S 4M1, Canada

McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario L8S 4M1, Canada

Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada

Department of Biology, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada

Centre for Advanced Light Microscopy, McMaster University, Hamilton, Ontario L8S 4M1, Canada

Brockhouse Institute for Materials Research, McMaster University, Hamilton, Ontario L8S 4M1, Canada

Funding

Ontario Ministry of Research and Innovation · Sick Kids Foundation · Canada Research Chairs · Natural Sciences and Engineering Research Council of Canada

References (57)

Show source-provided references
1. 10.1021/acs.chemrev.0c0008410.1021/acs.chemrev.0c00084 ↗
2. 10.1088/1758-5090/aa8dd810.1088/1758-5090/aa8dd8 ↗
3. 10.1089/ten.a.2007.000410.1089/ten.a.2007.0004 ↗
4. 10.1002/mabi.20200017910.1002/mabi.202000179 ↗
5. 10.1088/1758-5090/7/4/04501210.1088/1758-5090/7/4/045012 ↗
6. 10.1371/journal.pone.017762810.1371/journal.pone.0177628 ↗
7. 10.1088/1758-5082/6/2/02410510.1088/1758-5082/6/2/024105 ↗
8. 10.3389/fbioe.2020.0077610.3389/fbioe.2020.00776 ↗
9. 10.3389/fbioe.2021.61675310.3389/fbioe.2021.616753 ↗
10. 10.3389/fbioe.2021.77351110.3389/fbioe.2021.773511 ↗
11. 10.1021/acsami.0c1507810.1021/acsami.0c15078 ↗
12. 10.1016/j.addma.2020.10109710.1016/j.addma.2020.101097 ↗
13. 10.1088/1758-5090/8/2/02501610.1088/1758-5090/8/2/025016 ↗
14. 10.1126/sciadv.150065510.1126/sciadv.1500655 ↗
15. 10.1088/1758-5090/ab10ae10.1088/1758-5090/ab10ae ↗
16. 10.1038/s41598-020-61606-x10.1038/s41598-020-61606-x ↗
17. 10.3390/ma1103045410.3390/ma11030454 ↗
18. 10.1016/j.jmapro.2022.02.04810.1016/j.jmapro.2022.02.048 ↗
19. 10.1016/j.matdes.2018.09.04010.1016/j.matdes.2018.09.040 ↗
20. 10.1016/j.actbio.2020.11.00610.1016/j.actbio.2020.11.006 ↗
21. 10.1021/acsami.7b0361310.1021/acsami.7b03613 ↗
22. 10.1016/j.addma.2019.04.01310.1016/j.addma.2019.04.013 ↗
23. 10.1016/j.carbpol.2021.11797610.1016/j.carbpol.2021.117976 ↗
24. 10.1016/j.bprint.2021.e0013510.1016/j.bprint.2021.e00135 ↗
25. 10.1016/j.jnnfm.2012.07.00510.1016/j.jnnfm.2012.07.005 ↗
26. 10.1515/revce-2020-001610.1515/revce-2020-0016 ↗
27. 10.3390/fluids401000310.3390/fluids4010003 ↗
28. 10.1038/s41598-023-32007-710.1038/s41598-023-32007-7 ↗
29. 10.1002/adfm.20190097110.1002/adfm.201900971 ↗
30. 10.1016/j.ijpharm.2022.12256910.1016/j.ijpharm.2022.122569 ↗
31. 10.1088/1758-5090/8/3/03502010.1088/1758-5090/8/3/035020 ↗
32. 10.1002/adhm.20150067710.1002/adhm.201500677 ↗
33. 10.1021/acsami.7b0421610.1021/acsami.7b04216 ↗
34. 10.1016/j.bprint.2020.e0008010.1016/j.bprint.2020.e00080 ↗
35. 10.1021/jp044473u10.1021/jp044473u ↗
36. 10.1016/j.carbpol.2018.09.04410.1016/j.carbpol.2018.09.044 ↗
37. 10.1002/JBM.A.3256310.1002/JBM.A.32563 ↗
38. 10.3389/fceng.2021.72342910.3389/fceng.2021.723429 ↗
39. 10.1088/1758-5090/ab0cf610.1088/1758-5090/ab0cf6 ↗
40. 10.1021/acsbiomaterials.7b0037410.1021/acsbiomaterials.7b00374 ↗
41. 10.1016/j.biomaterials.2012.09.04810.1016/j.biomaterials.2012.09.048 ↗
42. 10.1242/jcs.19174210.1242/jcs.191742 ↗
43. 10.1007/s11831-019-09352-w10.1007/s11831-019-09352-w ↗
44. 10.1038/s41467-018-04336-z10.1038/s41467-018-04336-z ↗
45. 10.1016/j.matbio.2018.01.01910.1016/j.matbio.2018.01.019 ↗
46. 10.1021/acsabm.1c0097010.1021/acsabm.1c00970 ↗
47. 10.1177/036354652094184210.1177/0363546520941842 ↗
48. de Santis, M.; Ota, C.; Costa, R.; Doryab, A.; Alsafadi, H. In Development of a Hybrid Alginate-ECM Hydrogel as a Potential Bioink for 3D Bioprinting; European Respiratory Society, 2018.10.1183/13993003.congress-2018.LSC-1090 ↗
49. 10.1039/c004285d10.1039/c004285d ↗
50. 10.1165/rcmb.2014-0158OC10.1165/rcmb.2014-0158OC ↗
51. 10.1165/rcmb.2013-0047OC10.1165/rcmb.2013-0047OC ↗
52. 10.1515/ntrev-2020-007610.1515/ntrev-2020-0076 ↗
53. 10.2174/15680260878379090110.2174/156802608783790901 ↗
54. 10.1021/acs.langmuir.8b0023310.1021/acs.langmuir.8b00233 ↗
55. 10.1021/acsbiomaterials.6b0014910.1021/acsbiomaterials.6b00149 ↗
56. 10.3390/jfb1302004010.3390/jfb13020040 ↗
57. 10.3390/cells1006153810.3390/cells10061538 ↗